Promising Phase 3 Results For Green Valley’s Alzheimer’s Drug – Asian Scientist Magazine

December 5, 2018 by  
Filed under Alzheimers News

Sponsored By

Asian Scientist Magazine
Promising Phase 3 Results For Green Valley's Alzheimer's Drug
Asian Scientist Magazine
AsianScientist (Dec. 5, 2018) – Shanghai's Green Valley Pharmaceutical Co., Ltd. has announced promising findings from a Phase 3 clinical trial of GV-971, a multi-targeting carbohydrate-based drug for the treatment of mild-to-moderate Alzheimer's disease.

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!